Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Comparison of the spread of three botulinum toxin type A preparations.

Kerscher M, Roll S, Becker A, Wigger-Alberti W.

Arch Dermatol Res. 2012 Mar;304(2):155-61. doi: 10.1007/s00403-011-1179-z. Epub 2011 Oct 15.

PMID:
22002325
[PubMed - indexed for MEDLINE]
2.

Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.

Sattler G, Callander MJ, Grablowitz D, Walker T, Bee EK, Rzany B, Flynn TC, Carruthers A.

Dermatol Surg. 2010 Dec;36 Suppl 4:2146-54. doi: 10.1111/j.1524-4725.2010.01706.x.

PMID:
21134045
[PubMed - indexed for MEDLINE]
3.

Advances in the use of botulinum neurotoxins in facial esthetics.

Flynn TC.

J Cosmet Dermatol. 2012 Mar;11(1):42-50. doi: 10.1111/j.1473-2165.2011.00593.x. Review.

PMID:
22360334
[PubMed - indexed for MEDLINE]
4.

Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.

Hexsel D, Hexsel C, Siega C, Schilling-Souza J, Rotta FT, Rodrigues TC.

JAMA Dermatol. 2013 Dec;149(12):1386-91. doi: 10.1001/jamadermatol.2013.6440.

PMID:
24108521
[PubMed - indexed for MEDLINE]
5.

Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.

Prager W, Rappl T.

J Cosmet Dermatol. 2012 Dec;11(4):267-71. doi: 10.1111/jocd.12001. Epub 2012 Oct 2.

PMID:
23174049
[PubMed - indexed for MEDLINE]
6.

Diffusion of two botulinum toxins type A on the forehead: double-blinded, randomized, controlled study.

Jiang HY, Chen S, Zhou J, Leung KK, Yu P.

Dermatol Surg. 2014 Feb;40(2):184-92. doi: 10.1111/dsu.12405. Epub 2014 Jan 18.

PMID:
24438121
[PubMed - indexed for MEDLINE]
7.

The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina.

Banegas RA, Farache F, Rancati A, Chain M, Gallagher CJ, Chapman MA, Caulkins CA.

Aesthet Surg J. 2013 Sep 1;33(7):1039-45. doi: 10.1177/1090820X13503475. Epub 2013 Aug 29.

PMID:
23990584
[PubMed - indexed for MEDLINE]
8.

Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.

Hexsel D, Brum C, do Prado DZ, Soirefmann M, Rotta FT, Dal'Forno T, Rodrigues TC.

J Am Acad Dermatol. 2012 Aug;67(2):226-32. doi: 10.1016/j.jaad.2011.08.011. Epub 2011 Oct 29.

PMID:
22041253
[PubMed - indexed for MEDLINE]
9.

Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.

Flynn TC, Clark RE 2nd.

Dermatol Surg. 2003 May;29(5):519-22; discussion 522.

PMID:
12752521
[PubMed - indexed for MEDLINE]
10.

IncobotulinumtoxinA in esthetics.

Kerscher M, Yutskovskaya Y, Flynn TC.

J Drugs Dermatol. 2013 Jun 1;12(6):e111-20. Review.

PMID:
23839200
[PubMed - indexed for MEDLINE]
11.

A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines.

Moers-Carpi M, Dirschka T, Feller-Heppt G, Hilton S, Hoffmann K, Philipp-Dormston WG, Rütter A, Tan K, Chapman MA, Fulford-Smith A.

J Cosmet Laser Ther. 2012 Dec;14(6):296-303. doi: 10.3109/14764172.2012.738913. Epub 2012 Nov 15.

PMID:
23057624
[PubMed - indexed for MEDLINE]
12.

Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.

Yu KC, Nettar KD, Bapna S, Boscardin WJ, Maas CS.

Arch Facial Plast Surg. 2012 May-Jun;14(3):198-204. doi: 10.1001/archfacial.2011.1142.

PMID:
22183059
[PubMed - indexed for MEDLINE]
13.

Long-term results for incobotulinumtoxinA in the treatment of glabellar frown lines.

Rzany B, Flynn TC, Schlöbe A, Heinz M, Harrington L.

Dermatol Surg. 2013 Jan;39(1 Pt 1):95-103. doi: 10.1111/dsu.12008. Epub 2012 Nov 27.

PMID:
23190342
[PubMed - indexed for MEDLINE]
14.

International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.

Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, Monheit GD, Rzany B, Viel M.

J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1278-84. doi: 10.1111/j.1468-3083.2010.03631.x.

PMID:
20337830
[PubMed - indexed for MEDLINE]
15.

An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.

Nettar KD, Yu KC, Bapna S, Boscardin J, Maas CS.

Arch Facial Plast Surg. 2011 Nov-Dec;13(6):380-6. doi: 10.1001/archfacial.2011.37. Epub 2011 Jun 20. Erratum in: Arch Facial Plast Surg. 2012 Mar;14(2):140.

PMID:
21690460
[PubMed - indexed for MEDLINE]
16.

Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.

Michaels BM, Csank GA, Ryb GE, Eko FN, Rubin A.

Aesthet Surg J. 2012 Jan;32(1):96-102. doi: 10.1177/1090820X11430685.

PMID:
22231417
[PubMed - indexed for MEDLINE]
17.

Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.

Jandhyala R.

J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):720-31. doi: 10.1016/j.bjps.2011.12.001. Epub 2012 Jan 4.

PMID:
22225675
[PubMed - indexed for MEDLINE]
18.

Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study.

Cliff SH, Judodihardjo H, Eltringham E.

J Cosmet Dermatol. 2008 Mar;7(1):50-4. doi: 10.1111/j.1473-2165.2008.00361.x.

PMID:
18254812
[PubMed - indexed for MEDLINE]
19.

OnabotulinumtoxinA treatment of mild glabellar lines in repose.

Carruthers A, Carruthers J, Lei X, Pogoda JM, Eadie N, Brin MF.

Dermatol Surg. 2010 Dec;36 Suppl 4:2168-71. doi: 10.1111/j.1524-4725.2010.01708.x.

PMID:
21134048
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice.

Prager W, Huber-Vorländer J, Taufig AZ, Imhof M, Kühne U, Weissberg R, Kuhr LP, Rippmann V, Philipp-Dormston WG, Proebstle TM, Roth C, Kerscher M, Ulmann C, Pavicic T.

Clin Cosmet Investig Dermatol. 2012;5:53-8. doi: 10.2147/CCID.S26550. Epub 2012 Jun 8.

PMID:
22791996
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk